LONGO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 600
EU - Europa 306
AS - Asia 103
OC - Oceania 4
SA - Sud America 1
Totale 1.014
Nazione #
US - Stati Uniti d'America 600
PL - Polonia 144
CN - Cina 52
IT - Italia 40
TR - Turchia 26
DE - Germania 23
GB - Regno Unito 22
UA - Ucraina 21
SE - Svezia 16
SG - Singapore 15
BE - Belgio 11
AT - Austria 10
FI - Finlandia 8
FR - Francia 7
AU - Australia 4
ID - Indonesia 4
VN - Vietnam 3
NO - Norvegia 2
AL - Albania 1
EC - Ecuador 1
IQ - Iraq 1
JP - Giappone 1
RO - Romania 1
TW - Taiwan 1
Totale 1.014
Città #
Warsaw 144
Woodbridge 88
Ann Arbor 84
Fairfield 82
Chandler 50
Ashburn 38
Houston 37
Jacksonville 31
Seattle 31
Wilmington 30
Cambridge 25
Beijing 21
Izmir 17
Ferrara 12
Singapore 12
Brussels 11
Vienna 10
Bremen 9
Nanjing 9
Princeton 9
Shanghai 9
Boardman 7
Milan 6
San Diego 6
Cagliari 4
Cordignano 4
Jakarta 4
Changsha 3
Dong Ket 3
Falls Church 3
Redwood City 3
Auburn University 2
Des Moines 2
Göteborg 2
Helsinki 2
London 2
Melbourne 2
New York 2
Norwalk 2
Shenyang 2
Tappahannock 2
Tianjin 2
Washington 2
Bloomsbury 1
Bordeaux 1
Changchun 1
Chicago 1
Chiswick 1
Edinburgh 1
Erbil 1
Hebei 1
Indiana 1
Jiaxing 1
Jinan 1
Kunming 1
Leawood 1
Legnago 1
Los Angeles 1
Lucca 1
Mountain View 1
Nanchang 1
Orange 1
Paris 1
Quito 1
Santa Clara 1
Stockholm 1
Taipei 1
Tirana 1
Tokyo 1
Totale 852
Nome #
Altered motor phenotype and dopamine transmission associated with mutations of the parkinsonian gene LRRK2 203
D-Aspartate oxidase influences glutamatergic system homeostasis in mammalian brain 148
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 147
Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease 119
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging 111
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotics-Induced Weight-Gain. 108
Leucine-rich repeat kinase 2 (LRRK2) inhibitors differentially modulate glutamate release and Serine935 LRRK2 phosphorylation in striatal and cerebrocortical synaptosomes 78
null 77
L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter 35
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex 15
Totale 1.041
Categoria #
all - tutte 3.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.890


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020260 31 12 13 28 16 26 22 26 24 28 21 13
2020/2021185 14 23 7 16 10 19 6 24 9 27 20 10
2021/2022114 2 7 10 3 8 20 7 8 7 5 12 25
2022/2023138 10 14 11 12 30 16 8 11 12 0 9 5
2023/202473 13 5 4 0 6 8 3 11 2 2 1 18
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 1.041